The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
A new modality for immunosuppression: targeting the JAK/STAT pathway
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
STATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
Self-citationCools, J., DeAngelo, D. J., Gotlib, J., Stover, E. H., Legare, R. D., Cortes, J., Kutok, J., Clark, J., Galinsky, I., Griffin, J. D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025217 · Cited by 1,718
The lineage decisions of helper T cells
Murphy, K. M., & Reiner, S. L. (2002) · Nature Reviews Immunology · doi:10.1038/nri954 · Cited by 1,674
Interleukin-7 mediates the homeostasis of naïve and memory CD8 T cells in vivo
Schluns, K. S., Kieper, W. C., Jameson, S. C., & Lefrançois, L. (2000) · Nature Immunology · doi:10.1038/80868 · Cited by 1,618
Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.
Peschon, J. J., Morrissey, P. J., Grabstein, K. H., Ramsdell, F. J., Maraskovsky, E., Gliniak, B. C., Park, L. S., Ziegler, S. F., Williams, D. E., Ware, C. B., et al. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1955 · Cited by 1,555
Noguchi, M. (1993) · Cell · doi:10.1016/0092-8674(93)90167-o · Cited by 1,320
Parham, C., Chirica, M., Timans, J., Vaisberg, E., Travis, M., Cheung, J., Pflanz, S., Zhang, R., Singh, K. P., Vega, F., et al. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.11.5699 · Cited by 1,296
Regulatory T Cells in Autoimmmunity
Shevach, E. M. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.423 · Cited by 1,236
Transcription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“For these reasons, increasing attention is being paid to targeting these STATs for the treatment of cance”
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
(2017) · Arzneimittelforschung · doi:10.1055/s-00000175 · Cited by 1,134
O'Shea, J. J., Gadina, M., & Schreiber, R. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00701-8 · Cited by 1,119
Self-citationYoussef, S., Stüve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L., et al. (2002) · Nature · doi:10.1038/nature01158 · Cited by 1,097
Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene Therapy
Hacein-Bey-Abina, S., Le Deist, F., Carlier, F., Bouneaud, C., Hue, C., De Villartay, J.-P., Thrasher, A. J., Wulffraat, N., Sorensen, R., Dupuis-Girod, S., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012616 · Cited by 1,058
A Critical Role for IL-21 in Regulating Immunoglobulin Production
Ozaki, K., Spolski, R., Feng, C. G., Qi, C.-F., Cheng, J., Sher, A., Morse, H. C., Liu, C., Schwartzberg, P. L., & Leonard, W. J. (2002) · Science · doi:10.1126/science.1077002 · Cited by 978
The IL-12 Family of Heterodimeric Cytokines
Trinchieri, G., Pflanz, S., & Kastelein, R. A. (2003) · Immunity · doi:10.1016/s1074-7613(03)00296-6 · Cited by 922
Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
Meydan, N., Grunberger, T., Dadi, H., Shahar, M., Arpaia, E., Lapidot, Z., Leeder, J. S., Freedman, M., Cohen, A., Gazit, A., et al. (1996) · Nature · doi:10.1038/379645a0 · Cited by 897
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 877
A protein tyrosine kinase in the interferon αβ signaling pathway
Velazquez, L., Fellous, M., Stark, G. R., & Pellegrini, S. (1992) · Cell · doi:10.1016/0092-8674(92)90105-l · Cited by 872
Rodig, S. J., Meraz, M. A., White, J. M., Lampe, P. A., Riley, J. K., Arthur, C. D., King, K. L., Sheehan, K. C. F., Yin, L., Pennica, D., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81166-6 · Cited by 853
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
Puel, A., Ziegler, S. F., Buckley, R. H., & Leonard., W. J. (1998) · Nature Genetics · doi:10.1038/3877 · Cited by 813
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
Self-citationInterleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells
Becker, T. C., Wherry, E. J., Boone, D., Murali-Krishna, K., Antia, R., Ma, A., & Ahmed, R. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020369 · Cited by 683
Interaction of IL-2Rβ and γ c Chains with Jak1 and Jak3: Implications for XSCID and XCID
Russell, S. M., Johnston, J. A., Noguchi, M., Kawamura, M., Bacon, C. M., Friedmann, M., Berg, M., McVicar, D. W., Witthuhn, B. A., Silvennoinen, O., et al. (1994) · Science · doi:10.1126/science.7973658 · Cited by 655
Self-citationWitthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T., & Ihle, J. N. (1994) · Nature · doi:10.1038/370153a0 · Cited by 613
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
Changelian, P. S., Flanagan, M. E., Ball, D. J., Kent, C. R., Magnuson, K. S., Martin, W. H., Rizzuti, B. J., Sawyer, P. S., Perry, B. D., Brissette, W. H., et al. (2003) · Science · doi:10.1126/science.1087061 · Cited by 607
Self-citationPhosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2
Johnston, J. A., Kawamura, M., Kirken, R. A., Chen, Y.-Q., Blake, T. B., Shibuya, K., Ortaldo, J. R., McVicar, D. W., & O'Shea, J. J. (1994) · Nature · doi:10.1038/370151a0 · Cited by 595
Self-citationFunctional Activation of Jak1 and Jak3 by Selective Association with IL-2 Receptor Subunits
Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N., et al. (1994) · Science · doi:10.1126/science.7973659 · Cited by 589
Cytokine Requirements for Acute and Basal Homeostatic Proliferation of Naive and Memory CD8+ T Cells
Goldrath, A. W., Sivakumar, P. V., Glaccum, M., Kennedy, M. K., Bevan, M. J., Benoist, C., Mathis, D., & Butz, E. A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020033 · Cited by 587
Antoine, C., Müller, S., Cant, A., Cavazzana-Calvo, M., Veys, P., Vossen, J., Fasth, A., Heilmann, C., Wulffraat, N., Seger, R., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12513-5 · Cited by 579
Genetic and pharmacological analysis of prostanoid receptor function
Narumiya, S., & FitzGerald, G. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13455 · Cited by 568
Constitutively activated Jak-STAT pathway in T cells transformed with HTLV-I
Migone, T.-S., Lin, J.-X., Cereseto, A., Mulloy, J. C., O'Shea, J. J., Franchini, G., & Leonard, W. J. (1995) · Science · doi:10.1126/science.7604283 · Cited by 557
Self-citationCutting Edge: The Common γ-Chain Is an Indispensable Subunit of the IL-21 Receptor Complex
Asao, H., Okuyama, C., Kumaki, S., Ishii, N., Tsuchiya, S., Foster, D., & Sugamura, K. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.1.1 · Cited by 541
Buckley, R. H., Schiff, R. I., Schiff, S. E., Markert, M. L., Williams, L. W., Harville, T. O., Roberts, J. L., & Puck, J. M. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70199-9 · Cited by 540
Schluns, K. S., Williams, K., Ma, A., Zheng, X. X., & Lefrançois, L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.4827 · Cited by 521
Interleukin-7: from bench to clinic
Fry, T. J., & Mackall, C. L. (2002) · Blood · doi:10.1182/blood.v99.11.3892 · Cited by 501
Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells
Seddon, B., Tomlinson, P., & Zamoyska, R. (2003) · Nature Immunology · doi:10.1038/ni946 · Cited by 456
In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells
Cooper, M. A., Bush, J. E., Fehniger, T. A., VanDeusen, J. B., Waite, R. E., Liu, Y., Aguila, H. L., & Caligiuri, M. A. (2002) · Blood · doi:10.1182/blood-2001-12-0293 · Cited by 455
Greenlund, A. C., Farrar, M. A., Viviano, B. L., & Schreiber, R. D. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06422.x · Cited by 454
Inhibitors of Cytokine Signal Transduction
Wormald, S., & Hilton, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r300030200 · Cited by 440
A novel anti-inflammatory role for simvastatin in inflammatory arthritis.
Leung, B. P., Sattar, N., Crilly, A., Prach, M., McCarey, D. W., Payne, H., Madhok, R., Campbell, C., Gracie, J. A., Liew, F. Y., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1524 · Cited by 434
Partial Impairment of Cytokine Responses in Tyk2-Deficient Mice
Karaghiosoff, M., Neubauer, H., Lassnig, C., Kovarik, P., Schindler, H., Pircher, H., McCoy, B., Bogdan, C., Decker, T., Brem, G., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00054-6 · Cited by 420
Immune Response in Stat2 Knockout Mice
Park, C., Li, S., Cha, E., & Schindler, C. (2000) · Immunity · doi:10.1016/s1074-7613(00)00077-7 · Cited by 415
Jaks, STATs, Cytokine Signal Transduction, and Immunoregulation: Are We There Yet?
O'Shea, J. J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80505-1 · Cited by 386
Self-citationDiabetic Neuropathy: An intensive review
Duby, J. J., Campbell, R. K., Setter, S. M., White, J. R., & Rasmussen, K. A. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.2.160 · Cited by 382
Agnello, D., Lankford, C. S. R., Bream, J., Morinobu, A., Gadina, M., O'Shea, J. J., & Frucht, D. M. (2003) · Journal of Clinical Immunology · doi:10.1023/a:1023381027062 · Cited by 378
Self-citationRegulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
SOCS-3 regulates onset and maintenance of TH2-mediated allergic responses
Seki, Y.-I., Inoue, H., Nagata, N., Hayashi, K., Fukuyama, S., Matsumoto, K., Komine, O., Hamano, S., Himeno, K., Inagaki-Ohara, K., et al. (2003) · Nature Medicine · doi:10.1038/nm896 · Cited by 362
Townsend, M. J., Fallon, P. G., Matthews, D. J., Smith, P., Jolin, H. E., & McKenzie, A. N. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00056-x · Cited by 328
The main function of IL-2 is to promote the development of T regulatory cells
Malek, T. R. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0603272 · Cited by 327
Shimoda, K., Kato, K., Aoki, K., Matsuda, T., Miyamoto, A., Shibamori, M., Yamashita, M., Numata, A., Takase, K., Kobayashi, S., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00055-8 · Cited by 319
The biology of Stat4 and Stat6
Wurster, A. L., Tanaka, T., & Grusby, M. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203485 · Cited by 309
Prevention of T Cell Anergy by Signaling Through the γ c Chain of the IL-2 Receptor
Boussiotis, V. A., Barber, D. L., Nakarai, T., Freeman, G. J., Gribben, J. G., Bernstein, G. M., D'Andrea, A. D., Ritz, J., & Nadler, L. M. (1994) · Science · doi:10.1126/science.7973657 · Cited by 307
Kawamura, M., McVicar, D. W., Johnston, J. A., Blake, T. B., Chen, Y. Q., Lal, B. K., Lloyd, A. R., Kelvin, D. J., Staples, J. E., Ortaldo, J. R., et al. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.14.6374 · Cited by 302
Self-citationInterleukin-7: master regulator of peripheral T-cell homeostasis?
Fry, T. J., & Mackall, C. L. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)02028-2 · Cited by 287
Interleukin-2 and interleukin-15: immunotherapy for cancer
Fehniger, T. A., Cooper, M. A., & Caligiuri, M. A. (2002) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(01)00021-1 · Cited by 280
Perspectives on the development of a molecularly targeted agent
Druker, B. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00025-9 · Cited by 273
Molecular Phylogeny within Type I Cytokines and Their Cognate Receptors
Boulay, J.-L., O'Shea, J. J., & Paul, W. E. (2003) · Immunity · doi:10.1016/s1074-7613(03)00211-5 · Cited by 259
Self-citationTurkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 255
Components of a stat recognition code: Evidence for two layers of molecular selectivity
Schindler, U., Wu, P., Rothe, M., Brasseur, M., & McKnight, S. L. (1995) · Immunity · doi:10.1016/1074-7613(95)90013-6 · Cited by 246
Primary Immunodeficiency Diseases Due to Defects in Lymphocytes
Buckley, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011023431806 · Cited by 244
Haddad, É., Landais, P., Friedrich, W., Gerritsen, B., Cavazzana, M., Morgan, G., Bertrand, Y., Fasth, A. L., Porta, F., Cant, A. J., et al. (1998) · PubMed · doi:10.1182/blood.v91.10.3646 · Cited by 243
Egwuagu, C. E., Yu, C.-R., Zhang, M., Mahdi, R. M., Kim, S. J., & Gery, I. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.7.3181 · Cited by 240
Photochemical preparation of a pyridone containing tetracycle: a Jak protein kinase inhibitor
Thompson, J. E., Cubbon, R. M., Cummings, R. T., Wicker, L. S., Frankshun, R., Cunningham, B. R., Cameron, P. M., Meinke, P. T., Liverton, N., Weng, Y., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00106-3 · Cited by 234
The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression
Ragimbeau, J. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg038 · Cited by 215
The Janus Protein Tyrosine Kinase Family and Its Role in Cytokine Signaling
Ihle, J. N. (1995) · Advances in Immunology · doi:10.1016/s0065-2776(08)60582-9 · Cited by 212
Manna, S. K., & Aggarwal, B. B. (1999) · PubMed · Cited by 208
Jak3 Is Associated with CD40 and Is Critical for CD40 Induction of Gene Expression in B Cells
Hanissian, S. H., & Geha, R. S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80281-2 · Cited by 205
Pulmonary overexpression of IL-9 induces Th2 cytokine expression, leading to immune pathology
Temann, U.-A., Ray, P., & Flavell, R. A. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213696 · Cited by 201
Patel, D. D., Gooding, M. E., Parrott, R. E., Curtis, K. M., Haynes, B. F., & Buckley, R. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421804 · Cited by 188
Manna, S. K., & Aggarwal, B. B. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.4.2095 · Cited by 187
Protein kinase C inhibitors as novel anticancer drugs
Jirousek, M. R., & Goekjian, P. G. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.12.2117 · Cited by 182
Leonard, W. J., Noguchi, M., Russell, S. M., & McBride, O. W. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00847.x · Cited by 179
Elder, R. T., Xu, X., Williams, J. W., Gong, H., Finnegan, A., & Chong, A. S. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.22 · Cited by 174
Siemasko, K., Chong, A. S.-F., Jäck, H.-M., Gong, H., Williams, J. W., & Finnegan, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1581 · Cited by 174
Sudbeck, E. A., Liu, X., Narla, R. K., Mahajan, S., Ghosh, S., Mao, C., & Uckun, F. M. (1999) · PubMed · Cited by 164
Turnley, A. M., Faux, C. H., Rietze, R. L., Coonan, J. R., & Bartlett, P. F. (2002) · Nature Neuroscience · doi:10.1038/nn954 · Cited by 162
Nath, N., Giri, S., Prasad, R., Singh, A. K., & Singh, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.2.1273 · Cited by 158
Goekjian, P. G., & Jirousek, M. R. (1999) · Current Medicinal Chemistry · doi:10.2174/092986730609220401153113 · Cited by 155
The Novel JAK-3 Inhibitor CP-690550 Is a Potent Immunosuppressive Agent in Various Murine Models
Kudlacz, E. M., Perry, B. D., Sawyer, P. S., Conklyn, M. J., McCurdy, S. P., Brissette, W. H., and, M. F., & Changelian, P. S. (2003) · American Journal of Transplantation · doi:10.1046/j.1600-6143.2003.00281.x · Cited by 154
Self-citationImpaired survival and proliferation in IL-7 receptor-deficient peripheral T cells
Maraskovsky, E., Teepe, M., Morrissey, P. J., Braddy, S., Miller, R. E., Lynch, D. H., & Peschon, J. J. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5315 · Cited by 153
Immunosuppressive agents in organ transplantation: past, present, and future.
Hong, J. C., & Kahan, B. D. (2000) · PubMed · Cited by 145
Unexpected Effects of FERM Domain Mutations on Catalytic Activity of Jak3
Zhou, Y., Chen, M., Cusack, N., Kimmel, L. H., Magnuson, K. S., Boyd, J. G., Lin, W., Roberts, J. L., Lengi, A. J., Buckley, R. H., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00398-7 · Cited by 143
Self-citationMcMillan, S. J., Bishop, B., Townsend, M. J., McKenzie, A. N., & Lloyd, C. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011732 · Cited by 142
Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency
Candotti, F., Oakes, S. A., Johnston, J. A., Giliani, S., Schumacher, R. F., Mella, P., Fiorini, M., Ugazio, A. G., Badolato, R., Notarangelo, L. D., et al. (1997) · Blood · doi:10.1182/blood.v90.10.3996 · Cited by 142
Self-citationChen, M., Cheng, A., Candotti, F., Zhou, Y.-J., Hymel, A., Fasth, A. L., Notarangelo, L. D., & O’Shea, J. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.947-956.2000 · Cited by 141
Self-citationAmin, H. M., Medeiros, L. J., Ma, Y., Feretzaki, M., Das, P., Leventaki, V., Rassidakis, G. Z., O’Connor, S. L., McDonnell, T. J., & Lai, R. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206849 · Cited by 137
Roberts, J. L., Lengi, A. J., Brown, S. M., Chen, M., Zhou, Y., O’Shea, J. J., & Buckley, R. H. (2003) · Blood · doi:10.1182/blood-2003-06-2104 · Cited by 136
Self-citationShaw, M. H., Boyartchuk, V., Wong, S., Karaghiosoff, M., Ragimbeau, J., Pellegrini, S., Müller, M. M., Dietrich, W. F., & Yap, G. S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1930781100 · Cited by 136
The use of antibodies against the IL-2 receptor in transplantation
Waldmann, T. A., & O’Shea, J. J. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80215-x · Cited by 135
Self-citationMutations in severe combined immune deficiency (SCID) due to JAK3 deficiency
Notarangelo, L. D., Mella, P., Jones, A., Basile, G. D. S., Savoldi, G., Cranston, T., Vihinen, M., & Schumacher, R. F. (2001) · Human Mutation · doi:10.1002/humu.1188 · Cited by 117
Kirken, R. A., Erwin, R. A., Taub, D. D., Murphy, W. J., Behbod, F., Wang, L., Pericle, F., & Farrar, W. L. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.6.891 · Cited by 110
Notarangelo, L. D., Giliani, S., Mazza, C., Mella, P., Savoldi, G., Rodriguez‐Pérez, C., Mazzolari, E., Fiorini, M., Duse, M., Plebani, A., et al. (2000) · Immunological Reviews · doi:10.1034/j.1600-065x.2000.17812.x · Cited by 102
Stepkowski, S. M., Erwin-Cohen, R. A., Behbod, F., Wang, M., Qu, X., Tejpal, N., Nagy, Z. S., Kahan, B. D., & Kirken, R. A. (2002) · Blood · doi:10.1182/blood.v99.2.680 · Cited by 96
Bright, J. J., Du, C., Coon, M. E., Sriram, S., & Klaus, S. J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.7015 · Cited by 89
Defective T-cell receptor γ gene rearrangement in interleukin-7 receptor knockout mice
Candéias, S. M., Peschon, J. J., Muegge, K., & Durum, S. K. (1997) · Immunology Letters · doi:10.1016/s0165-2478(97)00062-x · Cited by 70
Unexpected and variable phenotypes in a family with JAK3 deficiency
Frucht, D., Gadina, M., Jagadeesh, G., Aksentijevich, I. A., Takada, K., Bleesing, J., Nelson, J. W., Muul, L., Perham, G., Morgan, G., et al. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363802 · Cited by 69
Self-citationTargeting Janus Kinase 3 in Mast Cells Prevents Immediate Hypersensitivity Reactions and Anaphylaxis
Malaviya, R., Zhu, D., Dıbırdık, İ., & Uckun, F. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.38.27028 · Cited by 68
Behbod, F., Erwin-Cohen, R. A., Wang, M., Trawick, B. W., Qu, X., Verani, R. R., Kahan, B. D., Stepkowski, S. M., & Kirken, R. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.6.3724 · Cited by 64
Advances in the Understanding and Treatment of Human Severe Combined Immunodeficiency
Buckley, R. H. (2000) · Immunologic Research · doi:10.1385/ir:22:2-3:237 · Cited by 64
Multiple γc-dependent cytokines regulate T-cell development
Malek, T. R., Malek, T. R., Porter, B. O., & He, Y.-W. (1999) · Immunology Today · doi:10.1016/s0167-5699(98)01391-7 · Cited by 63
Lineage commitment in lymphocytes: controlling the immune response.
Lh, G. (2001) · PubMed · Cited by 61
Ćetković-Cvrlje, M., Roers, B. A., Waurzyniak, B. J., Liu, X., & Uckun, F. M. (2001) · Blood · doi:10.1182/blood.v98.5.1607 · Cited by 58
Chiang, P.-H., Wang, L., Bonham, C. A., Liang, X., Fung, J. J., Lü, L., & Qian, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.3.1355 · Cited by 56
Interleukin-2 Signaling and the Maintenance of Self-Tolerance
Nelson, B. H. (2001) · KARGER eBooks · doi:10.1159/000060549 · Cited by 52
Role of a JAK3-dependent biochemical signaling pathway in platelet activation and aggregation
Tibbles, H. E., Vassilev, A., Wendorf, H., Schonhoff, D., Zhu, D., Lorenz, D., Waurzyniak, B., Liu, X.-P., & Uckun, F. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m011405200 · Cited by 51
Yap, G. S., Ortmann, R., Shevach, E. M., & Sher, A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5720 · Cited by 48
Coon, M. E., Diegel, M. L., Leshinsky, N., & Klaus, S. J. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6567 · Cited by 48
IL-7–dependent human leukemia T-cell line as a valuable tool for drug discovery in T-ALL
Barata, J. T., Boussiotis, V. A., Yunes, J. A., Ferrando, A. A., Moreau, L. A., Veiga, J. P., Sallan, S. E., Look, A. T., Nadler, L. M., & Cardoso, A. A. (2003) · Blood · doi:10.1182/blood-2002-12-3861 · Cited by 47
Kirken, R. A., Erwin, R. A., Wang, L., Wang, Y., Rui, H., & Farrar, W. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.9.5097 · Cited by 47
Trieu, V. N., Liu, R., Liu, X., & Uckun, F. M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1905 · Cited by 44
Uckun, F. M., Roers, B. A., Waurzyniak, B. J., Liu, X., & Ćetković-Cvrlje, M. (2002) · Blood · doi:10.1182/blood.v99.11.4192 · Cited by 42
A Heritable Defect in IL-12 Signaling in B10.Q/J Mice. I. In Vitro Analysis
Ortmann, R., Smeltz, R. B., Yap, G. S., Sher, A., & Shevach, E. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.9.5712 · Cited by 40
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways
Candotti, F., Notarangelo, L. D., Visconti, R., & O’Shea, J. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15769 · Cited by 40
Self-citationRole of Janus Kinase 3 in Mast Cell-Mediated Innate Immunity against Gram-Negative Bacteria
Malaviya, R., Navara, C. S., & Uckun, F. M. (2001) · Immunity · doi:10.1016/s1074-7613(01)00184-4 · Cited by 39
Genetic models of abnormal apoptosis in lymphocytes
Refaeli, Y., Parijs, L. V., & Abbas, A. K. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01322.x · Cited by 38
Role of JAK3 in CD40-Mediated Signaling
Jabara, H. H., Buckley, R. H., Roberts, J. L., Lefranc, G., Loiselet, J., Khalil, G. E., & Geha, R. S. (1998) · Blood · doi:10.1182/blood.v92.7.2435 · Cited by 35
Malaviya, R., & Uckun, F. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0513 · Cited by 32
Narla, R. K., Liu, X. P., Klis, D., & Uckun, F. M. (1998) · PubMed · Cited by 29
Molecular aspects of primary immunodeficiencies: lessons from cytokine and other signaling pathways
Candotti, F., Notarangelo, L. D., Visconti, R., & O’Shea, J. J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215769 · Cited by 27
Self-citationSäemann, M. D., Zeyda, M., Diakos, C., Szekeres, A., Böhmig, G. A., Kelemen, P., Parolini, O., Stockinger, H. S. J., Prieschl, E. E., Stulnig, T. M., et al. (2003) · Transplantation · doi:10.1097/01.tp.0000065738.58742.a9 · Cited by 26
Wang, L. H., Kirken, R. A., Yang, X. Y., Erwin, R. A., DaSilva, L., Yu, C., & Farrar, W. L. (2000) · Blood · doi:10.1182/blood.v95.12.3816.012k29_3816_3822 · Cited by 16
Wasik, M. A., Nowak, I. A., Zhang, Q., & Shaw, L. M. J. (1998) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199809058363 · Cited by 16
Kirken, R. A., Erwin-Cohen, R. A., Behbod, F., Wang, M.-E., Stepkowski, S. M., & Kahan, B. D. (2001) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)02791-3 · Cited by 13
Cited by
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Altered macrophage differentiation and immune dysfunction in tumor development
Sica, A., & Bronte, V. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31422 · Cited by 1,238
JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease
O'Shea, J. J., & Plenge, R. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.014 · Cited by 1,138
Self-citationThe role of JAK/STAT signaling pathway and its inhibitors in diseases.
Xin, P., Xu, X., Deng, C., Liu, S., Wang, Y., Zhou, X., Ma, H., Wei, D., & Sun, S. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106210 · Cited by 1,010
Research Progress on the Relationship between Atherosclerosis and Inflammation
Zhu, Y., Xian, X., Wang, Z., Bi, Y., Chen, Q., Han, X., Tang, D., & Chen, R. (2018) · Biomolecules · doi:10.3390/biom8030080 · Cited by 872
Metadata
- Authors
- O'Shea, J. J., Pesu, M., Borie, D. C., & Changelian, P. S.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2004-07
- Volume
- 3
- Issue
- 7
- Pages
- 555-564
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1980927217
- Cited by
- 303
- References
- 130
- FWCI
- 0.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.